The updated guidance for people aged 16 and over recommends using smaller amounts of intravenous fluid initially for those at risk of serious illness or death due to sepsis. Patients should be ...

Of all the life-threatening conditions hospitals battle on a daily basis, sepsis is a particularly fickle beast. Despite the difficulties associated with diagnosing this complication, healthcare ...

Researchers conducted a multicountry, cluster-randomized study to evaluate the impact of the APT-Sepsis program on maternal outcomes.

A multi-country clinical trial has shown that a structured, sustainable approach to infection prevention and treatment can ...

Sepsis, a common and potentially deadly complication to an infection, is the leading cause of death in U.S. hospitals, accounting for 35% of in-hospital deaths. But as many as 87% of sepsis cases ...

A groundbreaking clinical trial conducted at the Austin Hospital in Melbourne has introduced a new ray of hope for the often-fatal diagnosis of sepsis. Sepsis “is the biggest killer in intensive care ...

A new discovery from the lab of YouYang Zhao, Ph.D., from Stanley Manne Children's Research Institute at Ann & Robert H.

Coronaviruses are a group of RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause respiratory tract infections that can range from mild to lethal. Mild illnesses in ...

This was driven in particular by a reduction in severe infection-related illness, defined as a deep surgical-site, deep ...

APT-Sepsis programme cuts maternal death and severe infection risk through better prevention, detection, and treatment.